| 688180 Stock | | | 29.36 0.77 2.56% |
CEO
Cong Li is CoCEO Director of Shanghai Junshi Biosciences
| Age | 60 |
| Address | Building 7, No. 6, Shanghai, China, 200126 |
| Phone | 86 21 6105 8800 |
| Web | https://www.junshipharma.com |
Shanghai Junshi Management Efficiency
The company has return on total asset
(ROA) of
(0.1052) % which means that it has lost $0.1052 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity
(ROE) of
(0.2694) %, meaning that it generated substantial loss on money invested by shareholders. Shanghai Junshi's management efficiency ratios could be used to measure how well Shanghai Junshi manages its routine affairs as well as how well it operates its assets and liabilities. At present, Shanghai Junshi's
Non Currrent Assets Other are projected to increase significantly based on the last few years of reporting. The current year's
Other Current Assets is expected to grow to about 781.6
M, whereas
Total Assets are forecasted to decline to about 8.3
B.
Shanghai Junshi Biosciences (688180) is traded on Shanghai Stock Exchange in China and employs 2,568 people. Shanghai Junshi is listed under Biotechnology category by Fama And French industry classification.
Management Performance
Shanghai Junshi Bios Leadership Team
Elected by the shareholders, the Shanghai Junshi's board of directors comprises two types of representatives: Shanghai Junshi inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Shanghai. The board's role is to monitor Shanghai Junshi's management team and ensure that shareholders' interests are well served. Shanghai Junshi's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Shanghai Junshi's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Sheng Yao, Senior Director | |
| Baohong Xu, Financial Director | |
| Hui Feng, Chief Director | |
| Xin Li, Executive Director | |
| Yingge Chen, Joint Secretary | |
| FCS FCIS, Joint Secretary | |
| Zhuobing Zhang, Deputy Director | |
| Lu Yuan, Assistant Department | |
| Xin Duan, Deputy Mang | |
| Cong Li, CoCEO Director | |
| Jianjun MD, CEO GM | |
| Qian Wei, Chief Officer | |
| Ning MD, Executive Board | |
| Jianjun Zou, CEO GM | |
| Jun Xiong, Executive Chairman | |
| Ning Li, Executive Board | |
| Gang Wang, Chief Director | |
Shanghai Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Shanghai Junshi a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Currently Active Assets on Macroaxis
Other Information on Investing in Shanghai Stock
Shanghai Junshi financial ratios help investors to determine whether Shanghai Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Shanghai with respect to the benefits of owning Shanghai Junshi security.